Order
25514-42-5
2H,16H-6,9-Etheno-1,24:11,15-dimethenopyrido[2',3':17,18][1,11]dioxacycloheneicosino[2,3,4-ij]isoquinolin-12-ol,3,4,4a,5,16a,17,18,19-octahydro-21,22,25-trimethoxy-4,17-dimethyl-, (4aS,16aR)-(9CI)
Order
25514-36-7
1H-5a,8-Methanocyclohepta[a]cyclopenta[f]naphthalene-7-carboxylicacid,1-(1,5-dimethylhexyl)-2,3,3a,3b,4,5,8,9,10,10a,10b,11,12,12a-tetradecahydro-10a,12a-dimethyl-,[1R-[1a(R*),3ab,3ba,10aa,10bb,12aa]]-
Order
25517-21-9
3-(pyrrolidin-1-yl)-N-(tricyclo[3.3.1.1~3,7~]dec-1-yl)propanamide hydrochloride (1:1)
25517-04-8,25517-17-3,25517-21-9,255-17-4,2551-74-8,25517-56-0 Supplier | KINGPHARM.GROUP
CMO CDMO service. KINGPHARM.GROUP supply 25517-04-8,25517-17-3,25517-21-9,255-17-4,2551-74-8,25517-56-0 and related compounds.
25517-17-3
25517-04-8
25517-21-9
2551-74-8
255-17-4
25517-56-0